Ppbp [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats

Hiroshi Takahashi, Jeffrey R. Kirsch, Kenji Hashimoto, Edythe D. London, Raymond C. Koehler, Richard J. Traystman

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

and PurposeWe tested the hypothesis that administration of 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a potent sigma-receptor ligand, during transient focal ischemia would affect early postischemic brain injury. MethodsHalothane-anesthetized cats underwent left middle cerebral artery occlusion for 90 minutes followed by 4 hours of reperfusion. Control cats received saline (n equals 10). Experimental cats (2 groups, n equals 10 per group) were treated with PPBP at a rate of 0.1 mu mol/kg per hour (PPBP-0.1) or administered 1 mu mol/kg per hour (PPBP-1) intravenously from 75 minutes after initiation of ischemia and continuing during the 4 hours of reperfusion. ResultsAs measured by the microsphere method, blood flow to the ipsilateral caudate nucleus was decreased similarly in all groups during ischemia. Blood flow to the ipsilateral inferior temporal cortex was decreased during ischemia in all groups but was higher in cats subsequently treated with PPBP at the highest dose, even before drug administration. There was no difference in blood flow to the ipsilateral caudate nucleus or inferior temporal cortex (area of greatest cortical injury) during reperfusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral hemisphere (control, 29 plus minus 5%; PPBP-0.1, 17 plus minus 3%; PPBP-1, 6 plus minus 1% of ipsilateral hemisphere; mean plus minus SEM) and caudate nucleus (control, 49 plus minus 5%; PPBP-0.1, 39 plus minus 6%; PPBP-1, 25 plus minus 5% of ipsilateral caudate nucleus) was less in cats treated with 1 mu mol/kg per hour of PPBP compared with cats treated with saline. Cats treated with 0.1 mu mol/kg per hour had a 45% smaller hemispheric injury volume than the control group without differences in intraischemic blood flow. Recovery of somatosensory evoked potential amplitude was greater in cats treated with PPBP-1 compared with control (control, 18 plus minus 11%; PPBP-0.1, 30 plus minus 14%; PPBP-1, 54 plus minus 14% of baseline). ConclusionsThese data indicate that sigma-receptors may play an important role in the mechanism of acute injury in both the cortex and the caudate nucleus after 90 minutes of transient focal ischemia in the cat. Because PPBP afforded protection when administered at the end of ischemia and during reperfusion, sigma-receptors may contribute to the progression of injury in ischemic border regions.

Original languageEnglish (US)
Pages (from-to)1676-1682
Number of pages7
JournalStroke
Volume26
Issue number9
DOIs
StatePublished - Sep 1995

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Ppbp [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats'. Together they form a unique fingerprint.

  • Cite this